C lustering or aggregation of receptor molecules is a common mechanism to initiate and to potentiate signaling from the cognate receptor. A variety of receptors have been shown to cluster upon stimulation: the TCR-CD3 complex (1, 2) , B cell receptor (BCR) 3 (3, 4) , CD40 (5, 6) , Fc⑀RI (7), CD95 (8 -10), CD28 (11) , TNFR (12) , platelet-derived growth factor receptor (13) , CD2, CD44, L-selectin, or integrins (14) . Many receptor molecules cluster in distinct cholesterol-and sphingolipidrich domains of the cell membrane termed rafts (15) (16) (17) . The self-association of sphingolipids and cholesterol favors the formation of a liquid-ordered status that separates sphingolipids and cholesterol from phospholipids in the cell membrane and finally forms raft domains (17) . Those domains were also named detergent-insoluble glycosphingolipid-enriched membrane domains (DIGs), because they are insoluble in some nonionic detergents. Some receptor molecules are constitutively present in those membrane rafts, whereas other receptor molecules translocate into rafts upon stimulation (16, 18) ; for example, the BCR (4, 19) or the Fc⑀RI (7) reside in the detergent-soluble membrane fraction before cognate stimulation and translocate into detergent-insoluble rafts within minutes after ligation. Translocation and clustering of the BCR or the Fc⑀RI in those rafts appears to be required for activation of early signaling events initiated by the BCR (4) or the Fc⑀RI (7) . In addition to the ability to recruit receptor molecules, sphingolipidrich rafts also contain many signaling molecules, including Srclike tyrosine kinases (20) or phospholipases (21) . Finally, raft structures appear to exclude other (inhibitory) enzymes, e.g., the tyrosine phosphatase CD45 (4, 22) . The selective interaction of clustered receptor molecules with signaling molecules in rafts probably constitutes a central element in the initiation of receptor signaling.
We have recently suggested a new concept for receptor clustering using CD95 as the paradigm (9, 10, 23) . CD95 stimulation triggers a translocation of acid sphingomyelinase (ASM) from intracellular stores onto the extracellular leaflet of the cell membrane (9) . Electron microscopy studies localized the ASM in intracellular vesicles of unstimulated cells (23) and exposure of the ASM on the extracellular leaflet of the cell membrane is most likely mediated by the fusion of those vesicles (9, 23) with the cell membrane upon CD95 stimulation. Surface ASM localized to sphingolipid-rich rafts released extracellularly oriented ceramide and triggered a clustering of CD95 upon stimulation of lymphocytes via CD95 (9, 10) . Ceramide was required and sufficient to trigger the clustering of CD95 in sphingolipid-rich signaling platforms. Previous studies (24, 25) on IL-1 and p75 nerve growth factor receptors support the notion of ASM activity in rafts. The exact identity of surface ASM is still unknown, because cells contain at least two isoforms of ASM, a lysosomal ASM and a secretory ASM (26, 27) . The two forms are derived from the same gene, but are differentially processed at the amino terminus and display a different glycosylation pattern (27) . Whether surface ASM represents a third isoform or a specialized form of the secretory or lysosomal ASM, respectively, has to be determined.
CD95 exhibits sequence homology to CD40 (28) raising the question of whether ASM and ceramide are involved in signaling and clustering of CD40. CD40 has been shown to be central in the stimulation of B cells, because B lymphocytes lacking signals via CD40 are unable to switch from IgM to IgG synthesis upon antigenic stimulation (29, 30) . Ligation of CD40 results in the association of the receptor with several intracellular proteins including TNFR-associated factors (TRAFs; Refs. 31 and 32; for review see Ref. 33 ) and Janus family kinase 3 (JAK3; Ref. 34) . TRAFs couple CD40 to an activation of NF-B (35) and extracellular-regulated kinase (36) , JAK3 to the STATs (34), and thus, finally to gene transcription. In addition, CD40 stimulation triggers an activation of several Src-like tyrosine kinases, in particular Lyn (37) , Blk (38) , and Fyn (39) , as well as of the protein tyrosine kinase, Syk (39) . Activation of these kinases by CD40 correlates with a release of inositol-3-phosphate (37) , stimulation of Ras (38) , extracellular-regulated kinases (38, 40) , c-Jun N-terminal kinases (JNKs; Refs. 40 -42) , and p38 mitogen-activated protein kinase (42) .
However, most, if not all, of these signaling events seem to depend on the clustering and recruitment of CD40 in sphingolipid-rich rafts, at least in dendritic cells (5) and B lymphocytes (6) . Therefore, we aimed in the present study to define mechanisms mediating the aggregation of CD40 in rafts and the formation of a larger CD40 cluster. To this end, we investigated the role of the ASM and ceramide released in sphingolipid-rich membrane rafts for CD40 clustering.
Materials and Methods

Cells and stimulation
Human JY B lymphocytes, Niemann-Pick disease type A (NPDA) B lymphocytes, or Farber B lymphocytes were transfected with expression plasmids encoding ASM, vesicular stomatitis virus (VSV)-tagged ASM, Myctagged ASM, acid ceramidase (AC), or a control vector. NPDA cells were obtained from a patient with NPDA disease and Farber B cells were provided by Dr. K. Ferlinz (University of Bonn, Bonn, Germany). To retransfect the cells, we subcloned cDNAs encoding unmodified ASM, VSVtagged ASM, and AC into the pJK vector. These subclones were designated pJK-asm, pJK-vsv-asm, and pJK-ac, respectively (43, 44) . The pJK vector contains an additional gene that encodes a single-chain Ab fused with a Myc-tag to permit isolation of transfected cells by panning with the anti-Myc 9E10 Ab. In addition, the cDNA fragments encoding unmodified ASM and Myc-tagged ASM were subcloned into the pEF vector and designated pEF-asm and pEF-myc-asm, respectively. Both pJK and pEF vectors contain the elongation factor promoter to induce constitutive expression of ASM. Transient transfection of NPDA B lymphocytes was performed by using a BTX electroporator (Genetronics, San Diego, CA) that administered five 99-s pulses at 550 V. Stably transfected cells were selected with 0.75 mg/ml G418, which was removed at least 24 h before any signaling studies were performed. Expression of ASM constructs was confirmed by flow cytometry and by measurements of ASM activity that indicated an expression level comparable to that in normal control JY B cells.
All cells were grown in RPMI 1640 supplemented with 10% FBS, 10 mM of HEPES (pH 7.4), 2 mM of L-glutamine, 1 mM of sodium pyruvate, 100 M of nonessential amino acids, 100 U/ml penicillin, 100 g/ml streptomycin, and 50 M of 2-ME (Life Technologies, Karlsruhe, Germany). The mouse IgG1 anti-CD40 mAb (clone 5C3) was obtained from BD PharMingen (San Diego, CA). Anti-VSV P5D4 and anti-Myc 9E10 Abs were obtained from Roche (Mannheim, Germany), the anti-ceramide 15B4 mAb was obtained from Alexis (Grunberg, Germany), choleratoxin and anti-choleratoxin Abs from Sigma-Aldrich (Deisenhofen, Germany), the anti-ASM antiserum was kindly provided from Dr. K. Sandhoff (University of Bonn). Unless otherwise indicated, anti-CD40 5C3 Abs were added to the cells at a concentration of 100 ng/ml for 10 min at 4°C, cells were washed and then stimulated by the addition of 1 g/ml F(abЈ) 2 fragments of anti-mouse Ig (BD PharMingen) at 37°C. The time points given in the results or the figures, respectively, refer to the time with anti-mouse Ig stimulation.
To disrupt sphingolipid-and cholesterol-rich rafts, we used 10 g/ml nystatin, 0.5 g/ml filipin, or 1 mM of ␤-cyclodextrin. These drugs, which destroy sphingolipid-enriched rafts by disrupting cholesterol metabolism, were added 15 min before stimulation by anti-CD40. ␣-cyclodextrin (1 mM) was used as control. C 16 -ceramide, C 20:4 arachidonic acid, sphingomyelin (SM), dihydro-C 2 -ceramide, and dihydro-C 16 -ceramide were dissolved in 0.01% octyl-glucopyranoside and used at 1 M.
Fluorescence microscopy
For confocal and conventional fluorescence microscopy, lymphocytes were immobilized for 15 min on glass coverslips coated with 1% (v/v) poly L-lysine, washed, incubated with 100 ng/ml anti-CD40 5C3 Ab for 10 min at 4°C, washed again and stimulated for the indicated time with 1 g/ml F(abЈ) 2 anti-mouse Ig as above. Unstimulated cells were incubated with an irrelevant mouse IgG1 instead of anti-CD40 Abs. After the indicated time of stimulation, the cells were washed and fixed for 15 min in 1% (w/v) paraformaldehyde in PBS. Cells were washed and incubated with an irrelevant rabbit or human Ig (20 g/ml) for 45 min to block FcR before the addition of the primary Abs. Cells were washed again and then incubated for 45 min each with the anti-CD40 5C3 Ab (200 ng/ml), polyclonal goat anti-ASM antiserum (1/100 dilution), anti-ceramide mAb 15B4 (1/30 dilution) or choleratoxin (10 g/ml), respectively. The anti-CD40 5C3 Ab was visualized with a cyanine 3.18 (Cy3)-coupled anti-mouse Ig Ab, the anti-ASM Ab was displayed with a cyanine 5.18 (Cy5)-labeled anti-goat Ig Ab, the anti-ceramide Ab was visualized with a Cy5-labeled anti-mouse IgM, and choleratoxin was displayed with a Cy5-labeled anti-choleratoxin Ab. Control stainings were performed with irrelevant anti-mouse Ig mAbs or with pre-bled goat antiserum. Double stainings were performed with subsequent application of the indicated primary and secondary Abs. Fluorescence staining was viewed with a Nikon fluorescence microscope (Melville, NY) or a Leica TCS NT scanning confocal microscope (Munich, Germany). Fluorescence was analyzed by the simultaneous scanning of the two appropriate channels. Control samples were scanned separately and overlapping signals between different channels were compensated. Experiments using isotyped irrelevant primary Abs and the corresponding fluorescence-labeled secondary Abs were negative and confirmed the specificity of the results. Clustering was defined as one or several intense spots of fluorescence on the cell surface, whereas unstimulated cells displayed a homogenous distribution of the fluorescence throughout the membrane. In each experiment, the presence or absence of clustering in samples of 200 cells was scored by two independent observers. The results are given as the percentage of cells showing a cluster after the indicated time. All experiments were also performed without fixation in paraformaldehyde and revealed identical results.
Flow cytometry (FACS)
Cells in suspension were stained as described above using Cy3-labeled anti-ASM, Cy3-labeled anti-Myc-9E10 (1 g/ml; Roche), Cy3-labeled anti-VSV (1 g/ml; Roche) or Cy3-labeled anti-ceramide 15B4 (1/30 dilution), or isotype-matched irrelevant control mAbs and analyzed on a FACSCaliber (BD Biosciences, Franklin Lakes, NJ).
ASM activity
ASM activity was determined, as previously described (44, 45) . In brief, cells were lysed in 50 mM of Tris (pH 7.4), 10 mM of bacitracin, 1 mM of benzamidine, 1 mM of Na 3 VO 4 , 10 g/ml aprotinin and leupeptin (A/ L), 0.1 mg/ml soybean trypsin inhibitor, and 0.2% Triton X-100. They were then sonicated three times for 10 s each and the lysates were centrifuged for 2 min at 600 ϫ g. ASM lysis buffer that comprised equal amounts of 50 mM of Tris (pH 7.4), 3% Nonidet P-40, 1% Triton X-100, 1 mM of Na 3 VO 4 , and 100 g/ml A/L was added and ASM was immunoprecipitated by using goat anti-ASM Abs for 4 h at 4°C. Immunocomplexes were immobilized using protein A/G-coupled agarose (Santa Cruz Biotechnology, Heidelberg, Germany), washed three times with ASM lysis buffer, and then washed three times with 50 mM of sodium acetate (pH 5.0), 0.2% Triton X-100, 1 mM of Na 3 VO 4 , and 10 g/ml A/L. The complexes were then incubated for 30 min at 37°C with [ To analyze ASM activity on the cell surface, we stimulated 10 7 cells via CD40 ligation. We used a kit to biotinylate the cells according to the manufacturer's instructions (Pierce, Rockford, IL). The cells were washed and lysed in 50 mM of Tris (pH 7.4), 1% Triton X-100, 1 mM of Na 3 VO 4 , and 10 g/ml A/L. The lysates were subjected to precipitation with streptavidin-coupled agarose and the streptavidin precipitates were then analyzed for ASM activity, as described above.
Ceramide release
Cells were labeled for 48 h with 2 Ci/ml [ 3 H]serine (27 mCi/mmol; NEN). Cells were then stimulated via CD40 ligation and ceramide was extracted in a solution of CHCl 3 , CH 3 OH, H 2 O, and pyridine (dilution, 60/160/6/1). The lower phase was collected and dried, and the phospholipids contained therein were degraded with methanolic NaOH at 37°C for 2 h. Samples were re-extracted in a solution of CHCl 3 , CH 3 OH, and 1 M of HCl (dilution, 100/100/1), dried, and resuspended in a solution of CHCl 3 and CH 3 OH (dilution, 95/5). Lipids were separated on silica G60 thin-layer chromatography plates (Merck, Whitehouse Station, NJ) by using a solution of CHCl 3 , CH 3 
JNK activity
JY cells and ASM-deficient or reconstituted NPDA lymphocytes were stimulated for 20 min, lysed in 25 mM of HEPES (pH 7.4), 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, 125 mM of NaCl, 10 mM each of NaF, Na 3 VO 4 , and sodium pyrophosphate and 10 g/ml A/L. JNK was immunoprecipitated from the postcentrifugation lysates for 4 h at 4°C using polyclonal rabbit anti-human JNK antiserum (Santa Cruz Biotechnology). Immunocomplexes were immobilized on protein A/G (Santa Cruz Biotechnology), incubated for an additional 60 min at 4°C, washed twice in lysis buffer, twice in 132 mM of NaCl, 20 mM of HEPES, 5 mM of KCl, 1 mM of CaCl 2 , 0.7 mM of MgCl 2 , 0.8 mM of MgSO 4 , 1% Nonidet P-40, 2 mM of Na 3 VO 4 , once in 100 mM of Tris (pH 7.5), 0.5 M of LiCl, and, finally, twice in kinase buffer consisting of 12.5 mM of MOPS (pH 7.5), 12.5 mM of ␤-glycerophosphate, 0.5 mM of EGTA, 7.5 mM of MgCl 2 , 0.5 mM of NaF, 0.5 mM of Na 3 VO 4 . Samples were finally resuspended in kinase buffer supplemented with 10 Ci/sample [␥-
32 P]ATP (6000 Ci/ mmol; NEN; DuPont Pharmaceuticals, Wilmington, DE), 10 M of ATP, and 1 g/ml GST-c-Jun (aa 1-79), incubated at 30°C for 15 min and the kinase reaction was stopped by addition of 5 l of boiling 5ϫ reducing SDS sample buffer. Samples were separated by 10% SDS-PAGE and analyzed by autoradiography. The substrate GST-c-Jun was expressed in DH5␣-bacteria and purified via glutathione agarose. 
Results
ASM mediates CD40 clustering
To determine whether stimulation via CD40 ligation results in clustering of the receptor, we stimulated JY B cells by using crosslinked anti-CD40 Abs. Small clusters of CD40 formed on the cell surface within a few seconds (Fig. 1, A and B) . Within minutes of stimulation, these clusters enlarged and formed cap-like structures. The specificity of this clustering process is evident, because stimulation via CD40 ligation induced exclusive clustering of the cognate receptor (Fig. 1, C and D) , but not of other receptors, including CD95, BCR, L-selectin, or ␤ 2 integrin. Stimulation with a very high concentration of anti-CD40 (2 and 20 g/ml secondary F(abЈ) 2 (Fig. 1E) . Choleratoxin binds to GM1 gangliosides highly enriched in sphingolipid-rich rafts suggesting that CD40 clusters in those rafts.
To assess whether membrane changes affect receptor clustering, we investigated the role of ASM in CD40 clustering. To this end, we stimulated JY B cells via CD40 ligation and determined the activity of ASM and the release of ceramide. ASM activity rapidly increased ϳ2-fold upon CD40 ligation ( Fig. 2A) correlating with a release of ceramide (Fig. 2B) .
To investigate the function of ASM in CD40 clustering, we used human NPDA B lymphocytes, which are genetically deficient of ASM. The cells were either transfected with the ASM expression vector pJK-asm (NPDA/ASM ϩ/ϩ ) or with the control vector pJK (NPDA/ASM Ϫ/Ϫ ). ASM deficiency prevented CD40 clustering after stimulation via CD40 ligation; however, CD40 clustering was restored upon transfection of the ASM expression vector (Fig. 2C) . ASM deficiency did not result in a general defect of receptor clustering, because clustering of L-selectin, which does not activate ASM (46) , occurred in the NPDA/ASM Ϫ/Ϫ cells and the NPDA/ ASM ϩ/ϩ cells (Fig. 2C ). To further investigate the role of ceramide in receptor clustering, we tested CD40 clustering in AC-deficient B cells. AC metabolizes ceramide and thus may function as a negative regulator of ceramide activity. AC-deficient cells showed a marked increase in CD40 clustering (Fig. 2D) ; the level of clustering in AC-deficient cells transfected with the AC expression vector was similar to that seen in control B cells. These results indicate a role for ceramide in CD40 clustering, however, they do not exclude that some ceramide metabolites are also involved in CD40 clustering.
CD40 stimulation induces translocation of ASM onto the extracellular leaflet of the cell membrane
To gain insight into the mechanisms of ASM-mediated CD40 clustering, we investigated the subcellular distribution of ASM and whether ASM colocalizes with clustered CD40. FACS studies demonstrated a translocation of ASM from an intracellular location in unstimulated cells onto the cell surface after CD40-mediated stimulation (Fig. 3A) . Permeabilization of the cells with 0.1% Triton X-100 reveals that 10 -15% of the cellular ASM translocates to the cell surface upon stimulation. The specificity of our detection of ASM was demonstrated by transfection of Myctagged ASM and staining with Cy3-labeled anti-Myc 9E10 Ab and by transfection with VSV-tagged ASM and staining with anti-VSV P5D4 Ab (Fig. 3B) . To further confirm the translocation of functional ASM, we biotinylated surface proteins and measured ASM activity in streptavidin-selected immunoprecipitates. These studies revealed high ASM activity on the surface of stimulated cells but not of unstimulated cells (Fig. 3C) .
Confocal microscopy revealed that surface ASM and CD40 colocalized within the cluster region, whereas unstimulated cells displayed a homogenous distribution of CD40 and lacked surface ASM (Fig. 3D) .
Together, these results indicate that activated CD40 clusters and colocalizes with ASM, which translocates onto the extracellular surface of the plasma membrane upon stimulation.
Surface ceramide triggers clustering of activated CD40
On the basis of our results, we hypothesized that ASM generates extracellularly oriented ceramide upon stimulation of CD40. To test this hypothesis, we stained JY B lymphocytes before or after stimulation of CD40 with Cy3-labeled anti-ceramide 15B4 Ab. FACS showed that a substantial amount of the anti-ceramide Ab bound to the stimulated cells but not to unstimulated cells (Fig.  4A ). CD40 and ceramide colocalized in the cluster-like structure upon stimulation of the cells via CD40 (Fig. 4B) . Unstimulated cells almost completely lacked surface ceramide. The importance of extracellularly oriented ceramide for CD40 clustering is indicated by the abrogation of CD40 clustering upon neutralization of surface ceramide by the anti-ceramide 15B4 mAb (Fig. 4C) or the destruction of sphingolipid-rich rafts by ␤-cyclodextrin, nystatin, or filipin (Fig. 4D) . The inactive stereoisomer ␣-cyclodextrin did not affect CD40 clustering. Binding of the Ab to ceramide very likely alters the biophysical properties, e.g. the mobility, of the lipid and/or the ability of ceramide to interact with other lipids or proteins and, thus, the Ab is able to prevent the formation of receptor clusters.
Next, we investigated whether the generation of surface ceramide is sufficient to initiate CD40 clustering. When cells were treated with 100 ng/ml of anti-CD40 5C3 Ab that was not crosslinked, CD40 clustering did not occur (Fig. 5) . Combinations of noncross-linked 5C3 Ab and pure ASM or the Ab and natural C 16 -ceramide were sufficient to initiate CD40 clustering in NPDA/ ASM ϩ cells and to restore clustering in NPDA/ASM Ϫ cells (Fig.  5 ). Cross-linking of 100 ng/ml anti-CD40 5C3 Ab by a secondary F(abЈ) 2 (1 g/ml) also initiated CD40 clustering in ASM-expressing cells, but not in ASM-deficient B lymphocytes (Fig. 5) . The addition of the 5C3 Ab, pure ASM, or C 16 -ceramide alone did not induce CD40 clustering. Likewise, CD40 clustering was not induced by treatment of the cells with 5C3 anti-CD40 Abs and any of the following agents: arachidonic acid (C 20:4 ), SM, dihydro-C 2 -ceramide, or dihydro-C 16 -ceramide. A very high dose of anti-CD40 Abs (2 g/ml ϩ 20 g/ml secondary F(abЈ) 2 ) restored clustering of CD40 (Fig. 5 ) in ASM-deficient cells, which is very likely due to the forced formation of CD40 cluster by Ab aggregates.
These results support the notion that ceramide is necessary and sufficient for the clustering of activated CD40.
ASM-mediated CD40 clustering is required for CD40 signaling
We tested whether the activation of signaling events depends on clustering of CD40. Genetic deficiency of ASM, treatment with anti-ceramide Abs or destruction of rafts prevented CD40-mediated release of IL-12 (Fig. 6, A and B) . These findings indicate that CD40 clustering in ceramide-rich rafts is important for CD40-mediated cellular signaling. The failure of ASM-deficient cells to release IL-12 was dose-dependent and high doses of plate-bound anti-CD40 Abs restored, at least partially, IL-12 release (Fig. 6C) . Treatment of the cells with ␤-cyclodextrin, nystatin, or filipin did not affect surface translocation of the ASM (Fig. 6D) or activation (not shown) by CD40 indicating that signals occurring before CD40 clustering are not altered by the drugs.
To further indicate the significance of ASM-mediated clustering of CD40, we determined JNK activity in ASM-deficient or reconstituted NPDA cells or in cells treated with ␤-cyclodextrin or the inactive isomer ␣-cyclodextrin. ASM-deficient cells failed to activate JNK upon stimulation via CD40, while retransfection of ASM restored JNK activation (Fig. 6E) . Likewise, treatment of the cells with ␤-cyclodextrin abrogated CD40-mediated JNK activation, whereas ␣-cyclodextrin was without effect.
Discussion
Our data suggest a novel function of ceramide and the ASM, i.e., the mediation of CD40 clustering, which seems to be a critical event in transmembrane signaling through this receptor. Because we have previously demonstrated a similar function of ceramide and the ASM for CD95 (9, 10) and preliminary data also extend that function of ceramide and the ASM to CD48 and CD28 signaling (E. Gulbins, unpublished results) as well as to infection of some pathogenic bacteria into mammalian cells (9, 44, 47) , the observed function of the ASM might be operative for many receptor systems.
Our data suggest the following model of ASM-mediated clustering of CD40: primary stimulation via CD40, which seems to be insufficient to trigger complete cellular activation, induces an activation and membrane translocation of the ASM from an intracellular compartment, most likely vesicles, to the cell membrane. Fusion of ASM-containing vesicles with the cell membrane results in exposure of the ASM to the extracellular surface. ASM causes a localized release of extracellularly oriented ceramide and this molecule may function in several ways in the clustering process. First, ceramide has been shown to self-aggregate (48 -50) . A selfaggregation of ceramide in pre-existing sphingolipid-rich rafts may generate very small primary signaling microdomains. Second, because ceramide-rich microdomains spontaneously fuse (51), the generation of ceramide in those sphingolipid-rich rafts may trigger the fusion of those very small entities into larger membrane domains. The fusion of very small microdomains triggers the clustering of CD40 molecules already present in those rafts. Previous studies on dendritic cells and B lymphocytes (5, 6) , as well as preliminary data from our lab, indicate a substantial amount of CD40 in Triton X-100 insoluble membrane fractions already present before receptor stimulation suggesting that ceramide-mediated fusion of small rafts to larger platforms constitutes a major mechanism to cluster CD40. In addition, ceramide may also gather CD40 molecules into membrane rafts, prevent diffusion of CD40 molecules from rafts, or function in both ways. The findings from our studies on AC-deficient Farber lymphocytes as well as those from studies that included anti-ceramide 15B4 Ab binding strongly support a crucial role of ceramide in CD40 clustering. However, we cannot exclude the possibility that some metabolite(s) of ceramide, e.g., glycosylated ceramides, are involved in clustering, because some ceramide metabolites may also accumulate in Farber lymphocytes upon stimulation and may be detected by the anticeramide Abs. The FACS analysis and fluorescence microscopy examinations presented in this study revealed that the anticeramide Ab 15B4 did not bind to unstimulated cells, whereas binding occurred rapidly after stimulation of CD40. In addition, ASM-deficient cells failed to bind the Ab even after stimulation 6. CD40 clustering is required for CD40 signaling. Genetic deficiency of ASM, anti-ceramide 15B4 Ab-mediated neutralization of surface ceramide (A), or destruction of rafts by ␤-cyclodextrin, nystatin, or filipin (B) prevented release of IL-12 upon 24 h stimulation with plate-bound CD40. The inactive stereoisomer ␣-cyclodextrin had no effect. None of the reagents reduced viability of the cells and all samples showed ϳ2-3% dead cells after the 24 h incubation. To assess the effects of ␤-cyclodextrin, nystatin, filipin, or ␣-cyclodextrin, the fetal bovine concentration was reduced to 2.5%. All reagents were added 30 min before initiation of CD40 stimulation and re-added after a 12-h incubation period. Given is the mean Ϯ SD of three independent experiments. C, High doses of plate immobilized anti-CD40 (10 g/ml) restore IL-12 release from ASM-deficient cells, while lower doses require the ASM for efficient IL-12 release. ASMdeficient or reconstituted NPDA were incubated for 24 h with the indicated concentration of plate-bound CD40. IL-12 release was determined by ELISA. Given is the mean Ϯ SD of three independent experiments. High concentrations of plate-bound anti-CD40 very likely induce an artificial CD40 clustering abrogating the requirement of ASM for cell endogenous clustering. D, FACS analysis shows that treatment of JY cells with ␤-cyclodextrin, nystatin, or filipin does not alter the translocation of the ASM onto the cell surface upon stimulation via CD40, while lower concentrations of anti-CD40 require ASM expression for clustering and signaling. Shown is a representative analysis for three experiments. E, Deficiency of the ASM or destruction of rafts using ␤-cyclodextrin abrogates JNK activation upon CD40 triggering. Retransfection of the ASM restores JNK stimulation, the inactive isomer ␣-cyclodextrin was without effect on JNK stimulation. Nonspecific (n.s.) immunoprecipitates were performed with an irrelevant rabbit Ig and were negative. An aliquot of all immunoprecipitates was blotted with anti-JNK to confirm similar loading in all lanes. Shown is a representative blot from three independent kinase assays.
with anti-CD40 Ab. This result excludes the possibility of a substantive reaction with cholesterol, SM, or phospholipids. The observation that loading intact cells with C 16 -ceramide resulted in substantial Ab binding to the cell surface provides additional evidence of a specific detection of ceramide. Also, the anti-ceramide Ab detected a single band on high performance thin layer chromatography plates containing lipid extracts from CD40-stimulated cells and this band migrated to the same position as C 16 -ceramide. The anti-ceramide Ab did not detect dihydro-C 16 -ceramide or SM (E. Gulbins, unpublished data).
In the present study, we used several approaches to determine ASM translocation onto the cell surface; the specificity of these findings was confirmed by Ab staining of cells transfected with Myc-or VSV-tagged ASM constructs. In addition, the anti-ASM Ab failed to bind to B lymphocytes derived from ASM knockout mice, whereas B lymphocytes from normal control mice showed a rapid surface translocation of ASM upon CD40 ligation (E. Gulbins, unpublished observations).
Clustering of CD40 in rafts may serve many functions. First, multimerization of CD40 may permit the transactivation of molecules associated with CD40, e.g., JAK3 (34) , even if only a few dispersed molecules are primarily active. Second, translocation of CD40 may bring the receptor into close contact with signaling molecules present in rafts and may permit activation of these signaling molecules by CD40. Third, inhibitory signaling molecules, such as the tyrosine phosphatase CD45 (4, 22) , might be excluded from rafts, a situation that may further enhance signaling via CD40. Fourth, immobilization of CD40 in a defined membrane domain may stabilize the interaction of CD40 with its ligand. Lateral diffusion of raft-trapped CD40 might be greatly reduced; thus, the presence of CD40 in rafts may prolong binding to its ligand. Fifth, the translocation of CD40 into ceramide-enriched sphingolipid-rich rafts may promote interaction with and synergistic cell activation by other receptors, in particular, the BCR. Studies have shown that clustering of the BCR in membrane rafts is essential for its stimulatory functions (4, 19) ; however, whether CD40 and the BCR cluster in the same rafts remains unknown. Finally, the generation of ceramide in rafts may directly alter CD40 signaling, as recently shown for ceramide-dependent recruitment of caveolin 1 to receptor complexes in rafts, an activity that inhibits phosphatidylinositol 3-kinase (52).
In conclusion, CD40 ligation induces activation and surface translocation of ASM, which colocalizes with sphingolipid-rich membrane rafts. The activity of ASM causes the localized release of extracellularly oriented ceramide in sphingolipid-rich rafts, which in turn mediates clustering of CD40. Finally, CD40 clustering in ceramide-enriched rafts is required for the initiation of signaling within cells.
